Tan et al. developed a PEGylated anti-MUC1 aptamer-DOX complex for targeted drug delivery to breast cancer cells, demonstrating the macrophage evasion of drug could be decreased by PEGylation. The gene discussed is MUC1; the disease is breast carcinoma.